開示情報 > JIG-SAW receives U.S. patent approval for software-based cell control technology (The project NEW-VISION technology) in field of regenerative medicine

JIG-SAW receives U.S. patent approval for software-based cell control technology (The project NEW-VISION technology) in field of regenerative medicine

JIG-SAW receives U.S. patent approval for software-based cell control technology (The project NEW-VISION technology) in field of regenerative medicine

開示者 【39140】ＪＩＧ－ＳＡＷ株式会社
文書名 JIG-SAW receives U.S. patent approval for software-based cell control technology (The project NEW-VISION technology) in field of regenerative medicine  
PDF/XBRL [別ウインドウでPDFを開く]
開示日時 2021/01/18 チャネル/カテゴリ 東京証券取引所 /その他
ノート ログインするとIR文書にメモを入力して管理することができます
右上のログインメニューからログインしてください。


開示情報 > JIG-SAW receives U.S. patent approval for software-based cell control technology (The project NEW-VISION technology) in field of regenerative medicine